HEADER TRANSFERASE 06-JAN-22 7TFP TITLE HUMAN ORNITHINE AMINOTRANSFERASE COCRYSTALLIZED WITH ITS INHIBITOR, TITLE 2 (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLENE)CYCLOPENTANE-1-CARBOXYLIC ACID. COMPND MOL_ID: 1; COMPND 2 MOLECULE: ORNITHINE AMINOTRANSFERASE, MITOCHONDRIAL; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: ORNITHINE DELTA-AMINOTRANSFERASE,ORNITHINE--OXO-ACID COMPND 5 AMINOTRANSFERASE; COMPND 6 EC: 2.6.1.13; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: OAT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HUMAN ORNITHINE AMINOTRANSFERASE, HOAT, OAT, MECHANISM-BASED KEYWDS 2 INHIBITOR, MBI, IRREVERSIBLE INHIBITOR, INACTIVATOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.BUTRIN,W.ZHU,R.SILVERMAN,D.LIU REVDAT 3 18-OCT-23 7TFP 1 REMARK REVDAT 2 13-APR-22 7TFP 1 JRNL REVDAT 1 06-APR-22 7TFP 0 JRNL AUTH W.ZHU,A.BUTRIN,R.D.MELANI,P.F.DOUBLEDAY,G.M.FERREIRA, JRNL AUTH 2 M.T.TAVARES,T.S.HABEEB MOHAMMAD,B.A.BEAUPRE,N.L.KELLEHER, JRNL AUTH 3 G.R.MORAN,D.LIU,R.B.SILVERMAN JRNL TITL RATIONAL DESIGN, SYNTHESIS, AND MECHANISM OF (3 S ,4 R JRNL TITL 2 )-3-AMINO-4-(DIFLUOROMETHYL)CYCLOPENT-1-ENE-1-CARBOXYLIC JRNL TITL 3 ACID: EMPLOYING A SECOND-DEPROTONATION STRATEGY FOR JRNL TITL 4 SELECTIVITY OF HUMAN ORNITHINE AMINOTRANSFERASE OVER GABA JRNL TITL 5 AMINOTRANSFERASE. JRNL REF J.AM.CHEM.SOC. V. 144 5629 2022 JRNL REFN ESSN 1520-5126 JRNL PMID 35293728 JRNL DOI 10.1021/JACS.2C00924 REMARK 2 REMARK 2 RESOLUTION. 2.71 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.71 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.99 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 3 NUMBER OF REFLECTIONS : 37851 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.220 REMARK 3 FREE R VALUE TEST SET COUNT : 1976 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.9900 - 6.5300 0.92 2644 154 0.1799 0.2179 REMARK 3 2 6.5200 - 5.1800 0.90 2435 137 0.2082 0.2297 REMARK 3 3 5.1800 - 4.5300 0.95 2599 142 0.1767 0.2163 REMARK 3 4 4.5300 - 4.1100 0.96 2588 119 0.1895 0.2397 REMARK 3 5 4.1100 - 3.8200 0.97 2613 147 0.1990 0.2234 REMARK 3 6 3.8200 - 3.5900 0.97 2548 163 0.2185 0.2691 REMARK 3 7 3.5900 - 3.4100 0.97 2592 152 0.2488 0.3184 REMARK 3 8 3.4100 - 3.2700 0.97 2623 112 0.2726 0.2791 REMARK 3 9 3.2700 - 3.1400 0.94 2452 149 0.2700 0.3179 REMARK 3 10 3.1400 - 3.0300 0.92 2449 120 0.2972 0.3449 REMARK 3 11 3.0300 - 2.9400 0.97 2584 140 0.3151 0.4159 REMARK 3 12 2.9400 - 2.8500 0.98 2582 142 0.3277 0.3564 REMARK 3 13 2.8500 - 2.7800 0.98 2604 139 0.3336 0.3688 REMARK 3 14 2.7800 - 2.7100 0.98 2562 160 0.3332 0.3622 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.377 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.059 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 53.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.95 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 9719 REMARK 3 ANGLE : 0.485 13209 REMARK 3 CHIRALITY : 0.043 1462 REMARK 3 PLANARITY : 0.004 1696 REMARK 3 DIHEDRAL : 13.289 3575 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7TFP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JAN-22. REMARK 100 THE DEPOSITION ID IS D_1000262199. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-JUL-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.127 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : XIA2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37903 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.710 REMARK 200 RESOLUTION RANGE LOW (A) : 57.580 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.71 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.78 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1OAT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AFTER PURIFICATION, HOAT WAS BUFFER REMARK 280 EXCHANGED INTO THE CRYSTALLIZATION BUFFER (50 MM TRICINE PH 7.8) REMARK 280 SUPPLEMENTED WITH 1 MM 2-KETOGLUTARATE. THE PROTEIN WAS REMARK 280 CONCENTRATED TO 6.5 MG/ML. PREVIOUSLY REPORTED CRYSTALLIZATION REMARK 280 CONDITIONS WERE OPTIMIZED USING THE HANGING DROP VAPOR DIFFUSION REMARK 280 METHOD BY VARYING PEG 6000 (8-12%), NACL (100-250 MM), AND REMARK 280 GLYCEROL (0%-10%) WITH 100 MM TRICINE PH 7.8 BEING KEPT CONSTANT REMARK 280 AS THE BUFFER. FOR EACH HANGING DROP, 2 UL OF PROTEIN SOLUTION REMARK 280 WAS MIXED WITH AN EQUAL VOLUME OF WELL SOLUTION AND 0.5 UL OF REMARK 280 LIGAND. THE CRYSTALS WITH THE BEST MORPHOLOGY AND SIZE GREW IN A REMARK 280 FINAL CONDITION CONTAINING 12% PEG 6000, 200 MM NACL, 10% REMARK 280 GLYCEROL, AND 100 MM TRICINE PH 7.8. CRYSTALS WERE TRANSFERRED REMARK 280 TO A CRYO-PROTECTANT SOLUTION (WELL SOLUTION SUPPLEMENTED WITH REMARK 280 30% GLYCEROL) AND FLASH-FROZEN IN LIQUID NITROGEN., VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 124.54000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 62.27000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 62.27000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 124.54000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11410 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -61.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -62.27000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11430 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25690 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -64.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 -57.58500 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 -99.74015 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 -62.27000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 614 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 690 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 36 REMARK 465 PRO A 37 REMARK 465 GLY B 36 REMARK 465 PRO B 37 REMARK 465 GLY C 36 REMARK 465 PRO C 37 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS C 165 CG CD CE NZ REMARK 470 LYS C 167 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 N GLY B 142 O2P PLP B 501 1.30 REMARK 500 CA GLY B 142 O2P PLP B 501 2.07 REMARK 500 CG ASP A 263 C2A PLP A 501 2.14 REMARK 500 CG ASP C 263 C2A PLP C 501 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 53 44.81 -90.06 REMARK 500 PRO A 59 86.27 -65.48 REMARK 500 VAL A 88 57.62 -116.09 REMARK 500 THR A 109 -51.17 -120.73 REMARK 500 SER A 112 147.55 65.25 REMARK 500 ASN A 140 -60.34 -105.25 REMARK 500 PHE A 197 52.69 -116.98 REMARK 500 PRO A 199 171.77 -57.66 REMARK 500 LEU A 269 63.61 64.04 REMARK 500 LYS A 292 -89.83 56.24 REMARK 500 LEU A 312 3.17 -69.80 REMARK 500 ASN A 344 78.22 55.07 REMARK 500 LYS A 383 85.13 -69.28 REMARK 500 HIS A 408 14.32 -149.09 REMARK 500 HIS B 53 49.37 -92.13 REMARK 500 PRO B 59 73.11 -62.86 REMARK 500 VAL B 88 52.07 -117.65 REMARK 500 LYS B 107 -64.72 -93.44 REMARK 500 SER B 112 157.61 64.43 REMARK 500 GLU B 122 -58.57 56.80 REMARK 500 ASN B 132 62.12 60.08 REMARK 500 MET B 139 -166.81 -127.77 REMARK 500 TRP B 178 56.49 -158.49 REMARK 500 ARG B 180 42.97 -143.27 REMARK 500 LEU B 269 61.91 64.42 REMARK 500 LYS B 292 -91.36 56.30 REMARK 500 HIS C 53 35.76 -90.08 REMARK 500 HIS C 56 75.99 -119.59 REMARK 500 PRO C 59 83.31 -63.62 REMARK 500 VAL C 88 56.10 -110.76 REMARK 500 LYS C 107 -60.75 -90.28 REMARK 500 SER C 112 141.27 63.06 REMARK 500 ASN C 140 -65.86 -103.83 REMARK 500 VAL C 160 -54.01 -123.36 REMARK 500 LYS C 165 -121.33 36.97 REMARK 500 TYR C 166 61.67 -119.47 REMARK 500 TRP C 178 29.56 -145.60 REMARK 500 LYS C 292 -80.79 57.57 REMARK 500 HIS C 408 -19.49 -154.01 REMARK 500 REMARK 500 REMARK: NULL DBREF 7TFP A 36 439 UNP P04181 OAT_HUMAN 36 439 DBREF 7TFP B 36 439 UNP P04181 OAT_HUMAN 36 439 DBREF 7TFP C 36 439 UNP P04181 OAT_HUMAN 36 439 SEQRES 1 A 404 GLY PRO PRO THR SER ASP ASP ILE PHE GLU ARG GLU TYR SEQRES 2 A 404 LYS TYR GLY ALA HIS ASN TYR HIS PRO LEU PRO VAL ALA SEQRES 3 A 404 LEU GLU ARG GLY LYS GLY ILE TYR LEU TRP ASP VAL GLU SEQRES 4 A 404 GLY ARG LYS TYR PHE ASP PHE LEU SER SER TYR SER ALA SEQRES 5 A 404 VAL ASN GLN GLY HIS CYS HIS PRO LYS ILE VAL ASN ALA SEQRES 6 A 404 LEU LYS SER GLN VAL ASP LYS LEU THR LEU THR SER ARG SEQRES 7 A 404 ALA PHE TYR ASN ASN VAL LEU GLY GLU TYR GLU GLU TYR SEQRES 8 A 404 ILE THR LYS LEU PHE ASN TYR HIS LYS VAL LEU PRO MET SEQRES 9 A 404 ASN THR GLY VAL GLU ALA GLY GLU THR ALA CYS LYS LEU SEQRES 10 A 404 ALA ARG LYS TRP GLY TYR THR VAL LYS GLY ILE GLN LYS SEQRES 11 A 404 TYR LYS ALA LYS ILE VAL PHE ALA ALA GLY ASN PHE TRP SEQRES 12 A 404 GLY ARG THR LEU SER ALA ILE SER SER SER THR ASP PRO SEQRES 13 A 404 THR SER TYR ASP GLY PHE GLY PRO PHE MET PRO GLY PHE SEQRES 14 A 404 ASP ILE ILE PRO TYR ASN ASP LEU PRO ALA LEU GLU ARG SEQRES 15 A 404 ALA LEU GLN ASP PRO ASN VAL ALA ALA PHE MET VAL GLU SEQRES 16 A 404 PRO ILE GLN GLY GLU ALA GLY VAL VAL VAL PRO ASP PRO SEQRES 17 A 404 GLY TYR LEU MET GLY VAL ARG GLU LEU CYS THR ARG HIS SEQRES 18 A 404 GLN VAL LEU PHE ILE ALA ASP GLU ILE GLN THR GLY LEU SEQRES 19 A 404 ALA ARG THR GLY ARG TRP LEU ALA VAL ASP TYR GLU ASN SEQRES 20 A 404 VAL ARG PRO ASP ILE VAL LEU LEU GLY LYS ALA LEU SER SEQRES 21 A 404 GLY GLY LEU TYR PRO VAL SER ALA VAL LEU CYS ASP ASP SEQRES 22 A 404 ASP ILE MET LEU THR ILE LYS PRO GLY GLU HIS GLY SER SEQRES 23 A 404 THR TYR GLY GLY ASN PRO LEU GLY CYS ARG VAL ALA ILE SEQRES 24 A 404 ALA ALA LEU GLU VAL LEU GLU GLU GLU ASN LEU ALA GLU SEQRES 25 A 404 ASN ALA ASP LYS LEU GLY ILE ILE LEU ARG ASN GLU LEU SEQRES 26 A 404 MET LYS LEU PRO SER ASP VAL VAL THR ALA VAL ARG GLY SEQRES 27 A 404 LYS GLY LEU LEU ASN ALA ILE VAL ILE LYS GLU THR LYS SEQRES 28 A 404 ASP TRP ASP ALA TRP LYS VAL CYS LEU ARG LEU ARG ASP SEQRES 29 A 404 ASN GLY LEU LEU ALA LYS PRO THR HIS GLY ASP ILE ILE SEQRES 30 A 404 ARG PHE ALA PRO PRO LEU VAL ILE LYS GLU ASP GLU LEU SEQRES 31 A 404 ARG GLU SER ILE GLU ILE ILE ASN LYS THR ILE LEU SER SEQRES 32 A 404 PHE SEQRES 1 B 404 GLY PRO PRO THR SER ASP ASP ILE PHE GLU ARG GLU TYR SEQRES 2 B 404 LYS TYR GLY ALA HIS ASN TYR HIS PRO LEU PRO VAL ALA SEQRES 3 B 404 LEU GLU ARG GLY LYS GLY ILE TYR LEU TRP ASP VAL GLU SEQRES 4 B 404 GLY ARG LYS TYR PHE ASP PHE LEU SER SER TYR SER ALA SEQRES 5 B 404 VAL ASN GLN GLY HIS CYS HIS PRO LYS ILE VAL ASN ALA SEQRES 6 B 404 LEU LYS SER GLN VAL ASP LYS LEU THR LEU THR SER ARG SEQRES 7 B 404 ALA PHE TYR ASN ASN VAL LEU GLY GLU TYR GLU GLU TYR SEQRES 8 B 404 ILE THR LYS LEU PHE ASN TYR HIS LYS VAL LEU PRO MET SEQRES 9 B 404 ASN THR GLY VAL GLU ALA GLY GLU THR ALA CYS LYS LEU SEQRES 10 B 404 ALA ARG LYS TRP GLY TYR THR VAL LYS GLY ILE GLN LYS SEQRES 11 B 404 TYR LYS ALA LYS ILE VAL PHE ALA ALA GLY ASN PHE TRP SEQRES 12 B 404 GLY ARG THR LEU SER ALA ILE SER SER SER THR ASP PRO SEQRES 13 B 404 THR SER TYR ASP GLY PHE GLY PRO PHE MET PRO GLY PHE SEQRES 14 B 404 ASP ILE ILE PRO TYR ASN ASP LEU PRO ALA LEU GLU ARG SEQRES 15 B 404 ALA LEU GLN ASP PRO ASN VAL ALA ALA PHE MET VAL GLU SEQRES 16 B 404 PRO ILE GLN GLY GLU ALA GLY VAL VAL VAL PRO ASP PRO SEQRES 17 B 404 GLY TYR LEU MET GLY VAL ARG GLU LEU CYS THR ARG HIS SEQRES 18 B 404 GLN VAL LEU PHE ILE ALA ASP GLU ILE GLN THR GLY LEU SEQRES 19 B 404 ALA ARG THR GLY ARG TRP LEU ALA VAL ASP TYR GLU ASN SEQRES 20 B 404 VAL ARG PRO ASP ILE VAL LEU LEU GLY LYS ALA LEU SER SEQRES 21 B 404 GLY GLY LEU TYR PRO VAL SER ALA VAL LEU CYS ASP ASP SEQRES 22 B 404 ASP ILE MET LEU THR ILE LYS PRO GLY GLU HIS GLY SER SEQRES 23 B 404 THR TYR GLY GLY ASN PRO LEU GLY CYS ARG VAL ALA ILE SEQRES 24 B 404 ALA ALA LEU GLU VAL LEU GLU GLU GLU ASN LEU ALA GLU SEQRES 25 B 404 ASN ALA ASP LYS LEU GLY ILE ILE LEU ARG ASN GLU LEU SEQRES 26 B 404 MET LYS LEU PRO SER ASP VAL VAL THR ALA VAL ARG GLY SEQRES 27 B 404 LYS GLY LEU LEU ASN ALA ILE VAL ILE LYS GLU THR LYS SEQRES 28 B 404 ASP TRP ASP ALA TRP LYS VAL CYS LEU ARG LEU ARG ASP SEQRES 29 B 404 ASN GLY LEU LEU ALA LYS PRO THR HIS GLY ASP ILE ILE SEQRES 30 B 404 ARG PHE ALA PRO PRO LEU VAL ILE LYS GLU ASP GLU LEU SEQRES 31 B 404 ARG GLU SER ILE GLU ILE ILE ASN LYS THR ILE LEU SER SEQRES 32 B 404 PHE SEQRES 1 C 404 GLY PRO PRO THR SER ASP ASP ILE PHE GLU ARG GLU TYR SEQRES 2 C 404 LYS TYR GLY ALA HIS ASN TYR HIS PRO LEU PRO VAL ALA SEQRES 3 C 404 LEU GLU ARG GLY LYS GLY ILE TYR LEU TRP ASP VAL GLU SEQRES 4 C 404 GLY ARG LYS TYR PHE ASP PHE LEU SER SER TYR SER ALA SEQRES 5 C 404 VAL ASN GLN GLY HIS CYS HIS PRO LYS ILE VAL ASN ALA SEQRES 6 C 404 LEU LYS SER GLN VAL ASP LYS LEU THR LEU THR SER ARG SEQRES 7 C 404 ALA PHE TYR ASN ASN VAL LEU GLY GLU TYR GLU GLU TYR SEQRES 8 C 404 ILE THR LYS LEU PHE ASN TYR HIS LYS VAL LEU PRO MET SEQRES 9 C 404 ASN THR GLY VAL GLU ALA GLY GLU THR ALA CYS LYS LEU SEQRES 10 C 404 ALA ARG LYS TRP GLY TYR THR VAL LYS GLY ILE GLN LYS SEQRES 11 C 404 TYR LYS ALA LYS ILE VAL PHE ALA ALA GLY ASN PHE TRP SEQRES 12 C 404 GLY ARG THR LEU SER ALA ILE SER SER SER THR ASP PRO SEQRES 13 C 404 THR SER TYR ASP GLY PHE GLY PRO PHE MET PRO GLY PHE SEQRES 14 C 404 ASP ILE ILE PRO TYR ASN ASP LEU PRO ALA LEU GLU ARG SEQRES 15 C 404 ALA LEU GLN ASP PRO ASN VAL ALA ALA PHE MET VAL GLU SEQRES 16 C 404 PRO ILE GLN GLY GLU ALA GLY VAL VAL VAL PRO ASP PRO SEQRES 17 C 404 GLY TYR LEU MET GLY VAL ARG GLU LEU CYS THR ARG HIS SEQRES 18 C 404 GLN VAL LEU PHE ILE ALA ASP GLU ILE GLN THR GLY LEU SEQRES 19 C 404 ALA ARG THR GLY ARG TRP LEU ALA VAL ASP TYR GLU ASN SEQRES 20 C 404 VAL ARG PRO ASP ILE VAL LEU LEU GLY LYS ALA LEU SER SEQRES 21 C 404 GLY GLY LEU TYR PRO VAL SER ALA VAL LEU CYS ASP ASP SEQRES 22 C 404 ASP ILE MET LEU THR ILE LYS PRO GLY GLU HIS GLY SER SEQRES 23 C 404 THR TYR GLY GLY ASN PRO LEU GLY CYS ARG VAL ALA ILE SEQRES 24 C 404 ALA ALA LEU GLU VAL LEU GLU GLU GLU ASN LEU ALA GLU SEQRES 25 C 404 ASN ALA ASP LYS LEU GLY ILE ILE LEU ARG ASN GLU LEU SEQRES 26 C 404 MET LYS LEU PRO SER ASP VAL VAL THR ALA VAL ARG GLY SEQRES 27 C 404 LYS GLY LEU LEU ASN ALA ILE VAL ILE LYS GLU THR LYS SEQRES 28 C 404 ASP TRP ASP ALA TRP LYS VAL CYS LEU ARG LEU ARG ASP SEQRES 29 C 404 ASN GLY LEU LEU ALA LYS PRO THR HIS GLY ASP ILE ILE SEQRES 30 C 404 ARG PHE ALA PRO PRO LEU VAL ILE LYS GLU ASP GLU LEU SEQRES 31 C 404 ARG GLU SER ILE GLU ILE ILE ASN LYS THR ILE LEU SER SEQRES 32 C 404 PHE HET PLP A 501 15 HET PLP B 501 15 HET PLP C 501 15 HET I2V C 502 11 HETNAM PLP PYRIDOXAL-5'-PHOSPHATE HETNAM I2V (1S,3S,4S)-3-AMINO-4-(FLUOROMETHYL)CYCLOPENTANE-1- HETNAM 2 I2V CARBOXYLIC ACID HETSYN PLP VITAMIN B6 PHOSPHATE FORMUL 4 PLP 3(C8 H10 N O6 P) FORMUL 7 I2V C7 H12 F N O2 FORMUL 8 HOH *252(H2 O) HELIX 1 AA1 THR A 39 GLY A 51 1 13 HELIX 2 AA2 LEU A 82 ALA A 87 1 6 HELIX 3 AA3 HIS A 94 ASP A 106 1 13 HELIX 4 AA4 VAL A 119 ASN A 132 1 14 HELIX 5 AA5 THR A 141 VAL A 160 1 20 HELIX 6 AA6 THR A 181 SER A 187 1 7 HELIX 7 AA7 ASP A 190 ASP A 195 1 6 HELIX 8 AA8 ASP A 211 LEU A 219 1 9 HELIX 9 AA9 GLY A 244 HIS A 256 1 13 HELIX 10 AB1 LEU A 276 ASN A 282 5 7 HELIX 11 AB2 ASP A 307 LEU A 312 1 6 HELIX 12 AB3 ASN A 326 GLU A 342 1 17 HELIX 13 AB4 LEU A 345 MET A 361 1 17 HELIX 14 AB5 ASP A 389 ASN A 400 1 12 HELIX 15 AB6 LYS A 421 LEU A 437 1 17 HELIX 16 AB7 THR B 39 GLY B 51 1 13 HELIX 17 AB8 LEU B 82 ALA B 87 1 6 HELIX 18 AB9 HIS B 94 VAL B 105 1 12 HELIX 19 AC1 VAL B 119 ASN B 132 1 14 HELIX 20 AC2 THR B 141 VAL B 160 1 20 HELIX 21 AC3 THR B 181 SER B 186 1 6 HELIX 22 AC4 ASP B 190 ASP B 195 1 6 HELIX 23 AC5 ASP B 211 GLN B 220 1 10 HELIX 24 AC6 GLY B 244 HIS B 256 1 13 HELIX 25 AC7 LEU B 276 ASN B 282 5 7 HELIX 26 AC8 ASP B 307 LEU B 312 1 6 HELIX 27 AC9 ASN B 326 GLU B 343 1 18 HELIX 28 AD1 ASN B 344 MET B 361 1 18 HELIX 29 AD2 ASP B 389 ASN B 400 1 12 HELIX 30 AD3 LYS B 421 LEU B 437 1 17 HELIX 31 AD4 THR C 39 GLY C 51 1 13 HELIX 32 AD5 LEU C 82 ALA C 87 1 6 HELIX 33 AD6 HIS C 94 ASP C 106 1 13 HELIX 34 AD7 ASN C 117 ASN C 132 1 16 HELIX 35 AD8 THR C 141 VAL C 160 1 20 HELIX 36 AD9 THR C 181 SER C 187 1 7 HELIX 37 AE1 ASP C 190 ASP C 195 1 6 HELIX 38 AE2 ASP C 211 LEU C 219 1 9 HELIX 39 AE3 GLY C 244 HIS C 256 1 13 HELIX 40 AE4 LEU C 276 GLU C 281 5 6 HELIX 41 AE5 ASP C 307 LEU C 312 1 6 HELIX 42 AE6 ASN C 326 GLU C 343 1 18 HELIX 43 AE7 ASN C 344 MET C 361 1 18 HELIX 44 AE8 ASP C 389 ASN C 400 1 12 HELIX 45 AE9 LYS C 421 SER C 438 1 18 SHEET 1 AA1 4 LEU A 62 LYS A 66 0 SHEET 2 AA1 4 TYR A 69 ASP A 72 -1 O TRP A 71 N GLU A 63 SHEET 3 AA1 4 LYS A 77 ASP A 80 -1 O TYR A 78 N LEU A 70 SHEET 4 AA1 4 LEU A 402 LEU A 403 1 O LEU A 403 N PHE A 79 SHEET 1 AA2 7 LYS A 135 MET A 139 0 SHEET 2 AA2 7 SER A 302 CYS A 306 -1 O VAL A 304 N LEU A 137 SHEET 3 AA2 7 ILE A 287 LEU A 290 -1 N VAL A 288 O LEU A 305 SHEET 4 AA2 7 LEU A 259 ASP A 263 1 N PHE A 260 O ILE A 287 SHEET 5 AA2 7 VAL A 224 VAL A 229 1 N PHE A 227 O LEU A 259 SHEET 6 AA2 7 LYS A 169 ALA A 173 1 N LYS A 169 O ALA A 225 SHEET 7 AA2 7 PHE A 204 ILE A 207 1 O ASP A 205 N PHE A 172 SHEET 1 AA3 4 VAL A 368 LYS A 374 0 SHEET 2 AA3 4 LEU A 377 ILE A 382 -1 O ALA A 379 N ARG A 372 SHEET 3 AA3 4 ILE A 411 PHE A 414 -1 O PHE A 414 N ASN A 378 SHEET 4 AA3 4 LYS A 405 PRO A 406 -1 N LYS A 405 O ARG A 413 SHEET 1 AA4 4 LEU B 62 LYS B 66 0 SHEET 2 AA4 4 TYR B 69 ASP B 72 -1 O TRP B 71 N GLU B 63 SHEET 3 AA4 4 LYS B 77 ASP B 80 -1 O TYR B 78 N LEU B 70 SHEET 4 AA4 4 LEU B 402 LEU B 403 1 O LEU B 403 N PHE B 79 SHEET 1 AA5 7 LYS B 135 MET B 139 0 SHEET 2 AA5 7 SER B 302 CYS B 306 -1 O SER B 302 N MET B 139 SHEET 3 AA5 7 ILE B 287 LEU B 290 -1 N VAL B 288 O LEU B 305 SHEET 4 AA5 7 LEU B 259 ASP B 263 1 N PHE B 260 O ILE B 287 SHEET 5 AA5 7 VAL B 224 VAL B 229 1 N PHE B 227 O LEU B 259 SHEET 6 AA5 7 LYS B 169 ALA B 173 1 N LYS B 169 O ALA B 225 SHEET 7 AA5 7 PHE B 204 ILE B 207 1 O ILE B 207 N PHE B 172 SHEET 1 AA6 4 VAL B 368 LYS B 374 0 SHEET 2 AA6 4 LEU B 377 ILE B 382 -1 O VAL B 381 N THR B 369 SHEET 3 AA6 4 ILE B 411 PHE B 414 -1 O PHE B 414 N ASN B 378 SHEET 4 AA6 4 LYS B 405 PRO B 406 -1 N LYS B 405 O ARG B 413 SHEET 1 AA7 4 LEU C 62 LYS C 66 0 SHEET 2 AA7 4 TYR C 69 ASP C 72 -1 O TRP C 71 N GLU C 63 SHEET 3 AA7 4 LYS C 77 ASP C 80 -1 O TYR C 78 N LEU C 70 SHEET 4 AA7 4 LEU C 402 LEU C 403 1 O LEU C 403 N PHE C 79 SHEET 1 AA8 7 LYS C 135 MET C 139 0 SHEET 2 AA8 7 SER C 302 CYS C 306 -1 O SER C 302 N MET C 139 SHEET 3 AA8 7 ILE C 287 LEU C 290 -1 N LEU C 290 O ALA C 303 SHEET 4 AA8 7 LEU C 259 ASP C 263 1 N ALA C 262 O LEU C 289 SHEET 5 AA8 7 VAL C 224 VAL C 229 1 N PHE C 227 O LEU C 259 SHEET 6 AA8 7 LYS C 169 ALA C 173 1 N LYS C 169 O ALA C 225 SHEET 7 AA8 7 PHE C 204 ILE C 207 1 O ILE C 207 N PHE C 172 SHEET 1 AA9 3 VAL C 368 LYS C 374 0 SHEET 2 AA9 3 LEU C 377 ILE C 382 -1 O VAL C 381 N THR C 369 SHEET 3 AA9 3 ILE C 411 PHE C 414 -1 O ILE C 412 N ILE C 380 LINK OD2 ASP A 263 C2A PLP A 501 1555 1555 1.38 LINK NZ LYS A 292 C4A PLP A 501 1555 1555 1.43 LINK NZ LYS B 292 C4A PLP B 501 1555 1555 1.43 LINK OD2 ASP C 263 C2A PLP C 501 1555 1555 1.37 LINK NZ LYS C 292 C4A PLP C 501 1555 1555 1.49 LINK C4A PLP C 501 N07 I2V C 502 1555 1555 1.47 CRYST1 115.170 115.170 186.810 90.00 90.00 120.00 P 32 2 1 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008683 0.005013 0.000000 0.00000 SCALE2 0.000000 0.010026 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005353 0.00000